Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Rosiglitazone (Primary) ; Glibenclamide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 13 Jul 2011 Official Title amended as reported by ClinicalTrials.gov.
- 14 Apr 2009 Actual end date (Dec 2008), actual patient number (65), additional lead centres added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History